Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;99:723-730
Published online before print September 7, 2006, doi: 10.1161/01.RES.0000244015.10655.3f
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
99/7/723    most recent
01.RES.0000244015.10655.3fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cui, R.
Right arrow Articles by Brasier, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cui, R.
Right arrow Articles by Brasier, A. R.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Cell signalling/signal transduction
Right arrow Gene expression
Right arrow Genomics
Right arrow Growth factors/cytokines
(Circulation Research. 2006;99:723.)
© 2006 American Heart Association, Inc.


Molecular Medicine

RhoA Mediates Angiotensin II–Induced Phospho-Ser536 Nuclear Factor {kappa}B/RelA Subunit Exchange on the Interleukin-6 Promoter in VSMCs

Ruwen Cui, Brian Tieu, Adrian Recinos, Ronald G. Tilton, Allan R. Brasier

From the Department of Medicine (R.C., B.T., A.R., R.G.T., A.R.B.), Department of Biochemistry and Molecular Biology (B.T.), Stark Diabetes Center (R.G.T.), and Sealy Center for Molecular Medicine (A.R.B.), University of Texas Medical Branch, Galveston.

Correspondence to Allan R. Brasier, Division of Endocrinology, MRB 8.128, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555-1060. Email arbrasie{at}utmb.edu

The vasoconstrictor angiotensin II (Ang II) accelerates atherosclerosis by inducing vascular gene expression programs, producing monocyte recruitment, and vascular remodeling. In vascular smooth muscle cells (VSMCs), Ang II signaling activates interleukin (IL)-6 expression, a cytokine producing acute-phase inflammation, mediated by the transcription factor nuclear factor {kappa}B (NF-{kappa}B). The classical NF-{kappa}B activation pathway involves cytoplasmic-to-nuclear translocation of the potent RelA transactivating subunit; however, because nuclear RelA is present in VSMCs, the mechanism by which NF-{kappa}B activity is controlled is incompletely understood. In this study, we focus on early activation steps controlling RelA activation. Although Ang II only weakly induces {approx}1.5-fold RelA nuclear translocation, RelA is nevertheless required because short interfering RNA–mediated RelA knockdown inhibits inducible IL-6 expression. We find instead that Ang II stimulation rapidly induces RelA phosphorylation at serine residue 536, a critical regulatory site in its transactivating domain. Chromatin immunoprecipitation assays indicate no significant changes in total RelA binding to the native IL-6 promoter, but an apparent increase in fractional binding of phospho-Ser536 RelA. Inactivation of RhoA by treatment with Clostridium botulinum exoenzyme C3 exotoxin or expression of dominant negative RhoA blocks Ang II–inducible RelA Ser536 phosphorylation and IL-6 expression. Finally, enhanced phospho-Ser536 RelA formation in the aortae of rats chronically infused with Ang II was observed. Together, these data indicate a novel mechanism for Ang II–induced NF-{kappa}B activation in VSMCs, mediated by RhoA-induced phospho-Ser536 RelA formation, IL-6 expression, and vascular inflammation.


Key Words: RhoA • nuclear factor {kappa}B • vascular inflammation • atherosclerosis




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Takeda, T. Ichiki, E. Narabayashi, K. Inanaga, R. Miyazaki, T. Hashimoto, H. Matsuura, J. Ikeda, T. Miyata, and K. Sunagawa
Inhibition of Prolyl Hydroxylase Domain-Containing Protein Suppressed Lipopolysaccharide-Induced TNF-{alpha} Expression
Arterioscler Thromb Vasc Biol, December 1, 2009; 29(12): 2132 - 2137.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Jamaluddin, B. Tian, I. Boldogh, R. P. Garofalo, and A. R. Brasier
Respiratory Syncytial Virus Infection Induces a Reactive Oxygen Species-MSK1-Phospho-Ser-276 RelA Pathway Required for Cytokine Expression
J. Virol., October 15, 2009; 83(20): 10605 - 10615.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Pellieux, C. Montessuit, I. Papageorgiou, and R. Lerch
Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-{alpha}
Cardiovasc Res, May 1, 2009; 82(2): 341 - 350.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Holvoet and P. Sinnaeve
Angio-Associated Migratory Cell Protein and Smooth Muscle Cell Migration in Development of Restenosis and Atherosclerosis
J. Am. Coll. Cardiol., July 22, 2008; 52(4): 312 - 314.
[Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. E. Nowak, B. Tian, M. Jamaluddin, I. Boldogh, L. A. Vergara, S. Choudhary, and A. R. Brasier
RelA Ser276 Phosphorylation Is Required for Activation of a Subset of NF-{kappa}B-Dependent Genes by Recruiting Cyclin-Dependent Kinase 9/Cyclin T1 Complexes
Mol. Cell. Biol., June 1, 2008; 28(11): 3623 - 3638.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Y. Mong, C. Petrulio, H. L. Kaufman, and Q. Wang
Activation of Rho Kinase by TNF-{alpha} Is Required for JNK Activation in Human Pulmonary Microvascular Endothelial Cells
J. Immunol., January 1, 2008; 180(1): 550 - 558.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Choudhary, M. Lu, R. Cui, and A. R. Brasier
Involvement of a Novel Rac/RhoA Guanosine Triphosphatase-Nuclear Factor-{kappa}B Inducing Kinase Signaling Pathway Mediating Angiotensin II-Induced RelA Transactivation
Mol. Endocrinol., September 1, 2007; 21(9): 2203 - 2217.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Chen and B. L. Firestein
RhoA Regulates Dendrite Branching in Hippocampal Neurons by Decreasing Cypin Protein Levels
J. Neurosci., August 1, 2007; 27(31): 8378 - 8386.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Sahar, M. A. Reddy, C. Wong, L. Meng, M. Wang, and R. Natarajan
Cooperation of SRC-1 and p300 With NF-{kappa}B and CREB in Angiotensin II-Induced IL-6 Expression in Vascular Smooth Muscle Cells
Arterioscler Thromb Vasc Biol, July 1, 2007; 27(7): 1528 - 1534.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
J. Ruef, M. Browatzki, C. A. Pfeiffer, J. Schmidt, and R. Kranzhofer
Angiotensin II promotes the inflammatory response to CD40 ligation via TRAF-2
Vascular Medicine, February 1, 2007; 12(1): 23 - 27.
[Abstract] [PDF]